Supramolecular self-assembled nanoparticles that can overcome cisplatin resistance were constructed by utilizing a platinum(IV) prodrug bridged β-cyclodextrin dimer and adamantyl group modified porphyrin as the host and guest molecules, respectively.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: